Oestrogen receptor status of primary breast carcinomas and their metastases. Relation to pattern of spread and survival after recurrence

British Journal of Cancer

Volumn 60, Issue 2, 1989, Pages 252-257

  Kamby, C ^a   Rasmussen, B Bruun ^b   Kristensen, B ^a  

^a FINSEN LABORATORY   (Denmark)

^b Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; TAMOXIFEN;

AGE; BONE MARROW METASTASIS; BREAST CARCINOMA; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; FEMALE; HUMAN; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGE; RECEPTORS, ESTROGEN; SUPPORT, NON-U.S. GOV'T;

EID: 0024348260     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.1989.264     Document Type: Article

References (20)

1. ADAMI, H.-O., GRAFFMAN, S., LINDGREN, A. & SALLSTROM, J. (1985). Prognostic implications of estrogen receptor content in breast cancer. Breast Cancer Res. Treat., 5, 293.
2. ALANKO, A., HEINONEN, E., SCHEININ, T., TOLPPANEN, E.-M. & VIHKO, R. (1985). Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients. Cancer, 56, 1696.
3. ANDERSEN, J., ORNTOFT, T. & POULSEN, H.S. (1986). Semiquantitative oestrogen receptor assay in formalin fixed paraffin sections of human breast cancer tissue using monoclonal antibodies. Br. J. Cancer, 53, 691.
4. ANDERSEN, K.W., MOURIDSEN, H.T., CASTBERG, T. and 8 others (1981). Organisation of the Danish adjuvant trials in breast cancer. Dan. Med. Bull., 28, 102.
5. BROSS, I.D.J. (1954). Is there an increased risk? Fed. Proc., 13, 815.
6. CLARK, G.M., SLEDGE, G.W. JR., OSBORNE, C.K. & MCGUIRE, W.L. (1987). Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients. J. Clin. Oncol., 5, 55.
7. COX, D.R. (1972). Regression models and life tables. J. R. Stat. Soc., Series B, 34, 187.
8. DEROSA, C.M., OZELLO, L., GREENE, G.L. & HABIF, D.V. (1987). Immunostaining of estrogen receptor in paraffin sections of breast carcinomas using monoclonal antibody D75: effects of fixation. Am. J. Surg. Pathol., 11, 943.
9. HOEHN, J.L., PLOTKA, E.D. & DICKSON, K.B. (1976). Comparison of estrogen receptor levels in primary and regional metastatic carcinoma of the breast. Ann. Surg., 190, 69.
10. HOWELL, A., BARNES, D.M., HARLAND, R.N.L. and 6 others (1984). Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet, i, 588.
11. KAMBY, C., DIRKSEN, H., VEJBORG, I. and 4 others (1987a). Incidence and methodologic aspects of the occurrence of liver metastases in recurrent breast cancer. Cancer, 59, 1524.
12. KAMBY, C., GULDHAMMER, B., VEJBORG, I. and 4 others (1987b). The presence of tumor cells in bone marrow at the time of first recurrence of breast cancer. Cancer, 60, 1306.
13. KAMBY, C., ANDERSEN, J., EJLERTSEN, B. and 6 others (1988). Histological grade and steroid receptor content of primary breast cancer - impact on prognosis and possible modes of action. Br. J. Cancer, 58, 480.
14. LECLERCQ, G., HEUSON, J.C., DEBOEL, M.C. & MATTHEIM, W.H. (1975). Oestrogen receptors in breast cancer: a changing concept.. Br. Med. J., i, 185.
15. PARL, F.F., SCHMIDT, B.P., DUPONT, W.D. & WAGNER, R.K. (1984). Prognostic significance of estrogen receptor status in breast cancer in relation to tumor stage, axillary node metastasis, and histopathologic grading. Cancer, 54, 2237.
16. PETO, R., PIKE, M.C., ARMITAGE, P. and 7 others (1977). Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br. J. Cancer, 35, 1.
17. RASMUSSEN, B.B. & KAMBY, C. (1989). Immunohistochemical detection of estrogen receptors in paraffin sections from primary and metastatic breast cancer. Pathol. Res. Pract. (in the press).
18. ROSE, C., THORPE, S.M., ANDERSEN, K.W. and 4 others (1985). Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values. Lancet, 1, 16.
19. SHEK, L.L.M., GODOLPHIN, W. & SPINELLI, J.J. (1987). Oestrogen receptors, nodes and stage as predictors of post-recurrence survival in 457 breast cancer patients. Br. J. Cancer, 56, 825.
20. SILVESTRINI, R. (1981). Biological characteristics of breast cancer and their clinical relevants. In Commentaries on Research in Breast Disease, Bulbrook, R.D. & Taylor, D.J. (eds) p. 1. A llan R. Liss: New York.